Absorption |
Blood-Brain Barrier | BBB+ | 0.6318 |
Human Intestinal Absorption | HIA+ | 0.9907 |
Caco-2 Permeability | Caco2- | 0.6466 |
P-glycoprotein Substrate | Non-substrate | 0.5237 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8026 |
Non-inhibitor | 0.6635 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7657 |
Distribution |
Subcellular localization | Mitochondria | 0.5352 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7067 |
CYP450 2D6 Substrate | Non-substrate | 0.8032 |
CYP450 3A4 Substrate | Non-substrate | 0.5997 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6747 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8480 |
Inhibitor | 0.5391 |
AMES Toxicity | Non AMES toxic | 0.6433 |
Carcinogens | Non-carcinogens | 0.6985 |
Fish Toxicity | High FHMT | 0.9927 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.6781 |
Honey Bee Toxicity | Low HBT | 0.7792 |
Biodegradation | Not ready biodegradable | 0.9786 |
Acute Oral Toxicity | IV | 0.6165 |
Carcinogenicity (Three-class) | Non-required | 0.6229 |